Santen Pharmaceutical Co Ltd 2025 Integrated Report
The report reviews fiscal 2024 performance and presents Santen's FY2025-2029 growth plan. It identifies four most important materialities based on financial impact and reports a 72% global employee engagement score from a 93% response rate. The report also describes TCFD-based climate-risk analysis, a net-zero greenhouse-gas goal, and a 2030 Scope 1 and 2 emissions-reduction target.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Integrated Report
Pages: 66
Back to company
Santen Pharmaceutical Co Ltd
Santen Report
The report reviews fiscal 2024 performance and presents Santen's FY2025-2029 growth plan. It identifies four most important materialities based on financial impact and reports a 72% global employee engagement score from a 93% response rate. The report also describes TCFD-based climate-risk analysis, a net-zero greenhouse-gas goal, and a 2030 Scope 1 and 2 emissions-reduction target.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees